As with Rome IV, many clinicians would also choose to conduct baseline blood tests (including C-reactive protein) and stool tests (including fecal calprotectin and culture) for exclusion of infections, celiac disease, and inflammatory bowel disease (5). This evidence concerns the gene CRP and inflammatory bowel disease.